Tobacco giant Philip Morris International (PMI) has bought a 22.61 percent stake in British asthma inhaler maker Vectura. Following the deal, PMI announced that it plans to continue acquiring Vectura shares on the market at 165p (RUB167) per share. informs CNBC.
PMI is interested in Vectura, as it believes that in the future, the acquisition of the company will allow it to earn more. The cigarette maker is counting on the absorption of Vectura, intending increase their revenues from the sale of goods and services not related to nicotine, up to a billion dollars a year. It is assumed that PMI will gain access to inhaler technologies for the production of alternative smoking systems, however, the production of the asthma drugs Vectura will continue after the takeover.
Read Also
- Huawei confirms the design of the Huawei P50 with an official image Jun 3, 2021
- Call of Duty: Vanguard presentation trailer and release date! Aug 19, 2021
- Brawn: “I hope that the title is not awarded by the commissioners” | FormulaPassion.it Sep 14, 2021
- Côtes d’Armor: A walker takes a fatal fall from a cliff Nov 21, 2022
- Finistère: 2,000 sailors mobilized to simulate a nuclear accident at the Île Longue base Nov 23, 2022
- Google, we change: here is the core update of July, what happens Jul 9, 2021
- ANPA deplores that agricultural technicians were not included in Plan Sierra RD May 29, 2022